Palatin Technologies, Inc. (AMEX: PTN) Q2 2025 Earnings Call Transcript February 13, 2025 ...

Like why, for example, having diabetes can put you at ... (GLP-1), a hormone from a family of chemical messengers called the incretins, which Belgian physiologist Jean LaBarre first purified ...

Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...

Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...

All lines have been placed on mute to prevent any background noise. There will be a question-and-answer session at the ...

including the new class of glucagon-like peptide-1 receptor agonists. "What we don't know yet is how we can lower the risk for people with fatty muscles. For example, we don't know how treatments ...

Like why, for example, having diabetes can put you at higher risk of ... like peptide 1(GLP-1), a hormone from a family of chemical messengers called the incretins, which Belgian physiologist Jean ...

For example, a dollar invested in the broader market in 1927 ... driven by the success of its glucagon-like peptide-1 (GLP-1) receptor agonist drug portfolio. In the past 12 months, LLY has surged by ...

including the new class of glucagon-like peptide-1 receptor agonists. What we don't know yet is how we can lower the risk for people with fatty muscles. For example, we don't know how treatments ...

The management lowered their outlook because of “slower-than-anticipated growth in the U.S. incretin market and ... trade at a lower multiple. For example, if LLY's P/E falls to 30x and its ...